Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma

ClinicalTrials.gov ID: NCT01472757

Public ClinicalTrials.gov record NCT01472757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 12:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of VR506 Inhaled From a New Inhaler in Adolescent and Adult Subjects With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the clinical efficacy of three doses of VR506 delivered via a new dry powder inhaler for the treatment of asthma.

Study identification

NCT ID
NCT01472757
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Vectura Limited
Industry
Enrollment
374 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2011
Primary completion
Apr 30, 2013
Completion
Apr 30, 2013
Last update posted
Apr 20, 2020

2011 – 2013

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Vectura Clinical Trial Site 10038 Fountain Valley California 92708
Vectura Clinical Trial Site 10031 Los Angeles California 90048
Vectura Clinical Trial Site 10044 Mission Viejo California 92691
Vectura Clinical Trial Site 10022 Orange California 92868
Vectura Clinical Trial Site 10014 Rancho Mirage California 92270
Vectura Clinical Trial Site 10027 Rolling Hills Estates California 90274
Vectura Clinical Trial Site 10033 San Jose California 95117
Vectura Clinical Trial Site 10016 Vista California 90283
Vectura Clinical Trial Site 10023 Centennial Colorado 80112
Vectura Clinical Trial Site 10001 Colorado Springs Colorado 80907
Vectura Clinical Trial Site 10025 Denver Colorado 80230
Vectura Clinical Trial Site 10041 Sarasota Florida 34223
Vectura Clinical Trial Site 10011 Albany Georgia 31707
Vectura Clinical Trial Site 10002 Metairie Louisiana 70006
Vectura Clinical Trial Site 10042 Baltimore Maryland 21236
Vectura Clinical Trial Site 10029 North Dartmouth Massachusetts 02747
Vectura Clinical Trial Site 10008 Plymouth Minnesota 55441
Vectura Clinical Trial Site 10020 Warrensburg Missouri 64093
Vectura Clinical Trial Site 10009 Missoula Montana 59808
Vectura Clinical Trial Site 10034 Bellevue Nebraska 68123
Vectura Clinical Trial Site 10035 Omaha Nebraska 68114
Vectura Clinical Trial Site 10015 Omaha Nebraska 68130
Vectura Clinical Trial Site 10040 Rochester New York 14618
Vectura Clinical Trial Site 10010 Sylvania Ohio 43560
Vectura Clinical Trial Site 10017 Oklahoma City Oklahoma 73103
Vectura Clinical Trial Site 10028 Medford Oregon 97504
Vectura Clinical Trial Site 10024 Portland Oregon 97202
Vectura Clinical Trial Site 10021 Upland Pennsylvania 19013
Vectura Clinical Trial Site 10003 Charleston South Carolina 29407
Vectura Clinical Trial Site 10019 Boerne Texas 78006
Vectura Clinical Trial Site 10039 Waco Texas 76712
Vectura Clinical Trial Site 10004 Draper Utah 84020

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01472757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2020 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01472757 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →